ghk cu compound GHK-Cu (50) Research – Obsidian Labs Reta GLOW GHK-Cu (50mg) / Type:BPC+PEA 500 (60 Capsules)

ghk cu compound GHK-Cu (50) Research – Obsidian Labs Reta GLOW GHK-Cu (50mg) / Type:BPC+PEA 500 (60 Capsules)

GLOW GHK-Cu (50mg) / BPC-157 (10mg) / TB500 (10mg) - Your Peptide Brand

Those votes were still in progress at the time of publication

Reta

Type:BPC+PEA 500 (60 Capsules)

Proposed Mechanism BPC-157 appears to work through multiple pathways: Maintaining vesicular integrity (affecting VMATs and dopamine transporters) Possibly occupying its own vesicular storage sites Competing for dopamine receptor binding Functionally substituting when dopaminergic neurons are lost This last property, essentially “filling in” for missing dopamine function, would explain why the peptide counteracts both receptor agonists (apomorphine) and antagonists (haloperidol, fluphenazine, clozapine, sulpiride) with equal effectiveness